Page last updated: 2024-08-17

aspartic acid and dipyridamole

aspartic acid has been researched along with dipyridamole in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19906 (40.00)18.7374
1990's8 (53.33)18.2507
2000's1 (6.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Chan, TC; Kuczek, T1
Hiddemann, W; Köhne-Wömpner, CH; Rustum, Y; Schmoll, HJ1
Baselga, J; Casper, ES; Magill, GB; Markman, M; Ranhosky, A; Smart, TB1
Chan, TC; Cleary, S; Howell, SB; Markman, M2
Chan, TC; Howell, SB; King, ME; Taetle, R; Young, B1
Chan, TC; Howell, SB1
Brendel, BS1
Nakane, M1
Goz, B; Jeffs, L1
Morán, J; Pasantes-Morales, H; Peña, C; Sánchez-Olea, R1
Köhne, CH; Schmoll, HJ; Schöffski, P; Wilke, H1
Capizzi, RL; Case, L; Fernandes, DJ; Fleming, RA; Homesley, H; Loggie, BW; Morris, R; Muss, HB; Richards, F; Russell, GB; Smith, S1
Büchele, T; Dempke, W; Grothey, A; Schmoll, HJ1

Reviews

2 review(s) available for aspartic acid and dipyridamole

ArticleYear
The dead end of 5-fluorouracil double modulation and promise of continuous infusion schedules in the treatment of metastatic colorectal cancer.
    The Journal of infusional chemotherapy, 1996,Fall, Volume: 6, Issue:4

    Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Aspartate Carbamoyltransferase; Aspartic Acid; Clinical Trials, Phase II as Topic; Colorectal Neoplasms; Combined Modality Therapy; Dipyridamole; Drug Administration Schedule; Drug Synergism; Enzyme Inhibitors; Female; Fluorouracil; Humans; Immunologic Factors; Infusions, Intravenous; Injections, Intravenous; Interferons; Leucovorin; Liver Neoplasms; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasm Proteins; Nucleotides; Palliative Care; Phosphonoacetic Acid; Randomized Controlled Trials as Topic; Thymidylate Synthase

1996
Where do we stand with 5-fluorouracil?
    Seminars in oncology, 1999, Volume: 26, Issue:6

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Chronotherapy; Colorectal Neoplasms; Dipyridamole; Drug Synergism; Fluorouracil; Humans; Interferons; Leucovorin; Levamisole; Methotrexate; Phosphonoacetic Acid; Radiation-Sensitizing Agents; Trimetrexate; Zidovudine

1999

Trials

2 trial(s) available for aspartic acid and dipyridamole

ArticleYear
A phase II trial of PALA + dipyridamole in patients with advanced soft-tissue sarcoma.
    Cancer chemotherapy and pharmacology, 1991, Volume: 28, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Aspartic Acid; Dipyridamole; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Phosphonoacetic Acid; Sarcoma; Soft Tissue Neoplasms

1991
Phase I study of N-(phosphonacetyl)-L-aspartate with fluorouracil and with or without dipyridamole in patients with advanced cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1996, Volume: 2, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Aspartate Carbamoyltransferase; Aspartic Acid; Dipyridamole; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Leukocytes; Male; Middle Aged; Neoplasms; Phosphonoacetic Acid; Uridine Triphosphate

1996

Other Studies

11 other study(ies) available for aspartic acid and dipyridamole

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Mechanism-based model for tumor drug resistance.
    Cancer chemotherapy and pharmacology, 1992, Volume: 30, Issue:5

    Topics: Animals; Aspartic Acid; Cell Cycle; Cell Survival; Dipyridamole; Dose-Response Relationship, Drug; Drug Resistance; Models, Biological; Models, Statistical; Phosphonoacetic Acid; Pyrimidines; Tumor Cells, Cultured; Uridine

1992
The emerging role for biomodulation of antineoplastic agents.
    Seminars in oncology, 1992, Volume: 19, Issue:2 Suppl 3

    Topics: Antineoplastic Agents; Aspartic Acid; Dipyridamole; Fluorouracil; Humans; Immunologic Factors; Interferon-alpha; Phosphonoacetic Acid

1992
Plasma uridine changes in cancer patients treated with the combination of dipyridamole and N-phosphonacetyl-L-aspartate.
    Cancer research, 1986, Volume: 46, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Dipyridamole; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Organophosphorus Compounds; Phosphonoacetic Acid; Uridine

1986
Phase I trial of combination therapy of cancer with N-phosphonacetyl-L-aspartic acid and dipyridamole.
    Cancer chemotherapy and pharmacology, 1987, Volume: 19, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Dipyridamole; Drug Evaluation; Drug Synergism; Female; Gastrointestinal Diseases; Headache; Humans; Male; Middle Aged; Neoplasms; Organophosphorus Compounds; Phosphonoacetic Acid; Uridine

1987
Modulation of the activity of PALA by dipyridamole.
    Cancer treatment reports, 1985, Volume: 69, Issue:4

    Topics: Animals; Aspartic Acid; Biological Transport; Cell Line; Colonic Neoplasms; Dipyridamole; Drug Interactions; Humans; In Vitro Techniques; Lethal Dose 50; Leukemia, Myeloid; Melanoma; Mice; Mice, Nude; Organophosphorus Compounds; Phosphonoacetic Acid; Pyrimidine Nucleosides; Tritium; Uridine

1985
Mechanism of synergy between N-phosphonacetyl-L-aspartate and dipyridamole in a human ovarian carcinoma cell line.
    Cancer research, 1985, Volume: 45, Issue:8

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Cell Line; Dipyridamole; Drug Synergism; Female; Humans; Nucleotides; Organophosphorus Compounds; Ovarian Neoplasms; Phosphonoacetic Acid; Uridine

1985
[Cardiovascular complications in operated patients more than 70 years old suffering from cardiovascular insufficiency].
    Zeitschrift fur Alternsforschung, 1972, Volume: 26, Issue:1

    Topics: Age Factors; Aged; Aminophylline; Anesthesia, General; Aspartic Acid; Cardiac Surgical Procedures; Dipyridamole; Female; Glucose; Heart Failure; Humans; Lanatosides; Magnesium; Male; Postoperative Care; Postoperative Complications; Potassium; Premedication; Preoperative Care; Vascular Diseases

1972
[Experimental study on the selective intracoronary infusion, with special reference to its effect on acute coronary stenosis].
    Japanese circulation journal, 1968, Volume: 32, Issue:4

    Topics: Acute Disease; Animals; Aspartic Acid; Cardiac Catheterization; Cardiac Output; Coronary Disease; Coronary Vessels; Cytochromes; Dextrans; Dipyridamole; Dogs; Electrocardiography; Heparin; Infusions, Parenteral; Methods; Myocardium; Nucleosides; Oxidation-Reduction; Oxygen Consumption; Regional Blood Flow; Thiamine

1968
The enhancement of the frequency of resistance to N-phosphonoacetyl-L-aspartate and methotrexate by 1-beta-D-arabinofuranosylcytosine: the effect of dipyridamole.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 270, Issue:2

    Topics: Animals; Aspartic Acid; Cell Line, Transformed; Cricetinae; Cytarabine; Dipyridamole; Drug Resistance; Drug Synergism; Humans; Methotrexate; Nucleosides; Phosphonoacetic Acid; Thioinosine

1994
Inhibition of volume regulation and efflux of osmoregulatory amino acids by blockers of Cl- transport in cultured astrocytes.
    Neuroscience letters, 1993, Jun-25, Volume: 156, Issue:1-2

    Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Aspartic Acid; Astrocytes; Cells, Cultured; Chloride Channels; Chlorides; Dipyridamole; Dose-Response Relationship, Drug; Kinetics; Niflumic Acid; Rats; Taurine; Tritium; Water-Electrolyte Balance

1993